04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
The most frequently asked question at all-hands meetings for a securities offering is “What financi...
Read More >
Employers with at least 100 employees, and federal contractors with contract of at least $50,000 and...
Read More >
In recent months, European states have raced to implement protections against opportunistic acquisit...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
Let's be honest; we've all been there. You're running late for work. Your kid is late for football p...
Read More >
On December 1, 2020, the Court of Appeals of Texas (1st District) reversed a lower court decision an...
Read More >